1995
DOI: 10.1006/exnr.1995.1033
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Glial Cell Line-Derived Neurotrophic Factor on Developing and Mature Ventral Mesencephalic Grafts in Oculo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
39
0

Year Published

1996
1996
2009
2009

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 73 publications
(39 citation statements)
references
References 0 publications
0
39
0
Order By: Relevance
“…from diffuse and sparse to dense and patchy (Törnqvist et al, 2000). However, GDNF treatment of mature dopamine grafts did not affect survival and outgrowth from grafted dopamine neurons (Johansson et al, 1995;Winkler et al, 2006), but enhanced nerve fiber formation within the grafts, a phenomenon also found using other factors . This phenomenon may cause reduced graft function since high dopamine activity surrounding the grafted dopamine neurons should, theoretically, shut down neuronal activity for the dopamine neurons that target the host striatum, thus reducing dopamine release in the host target.…”
Section: Introductionmentioning
confidence: 74%
“…from diffuse and sparse to dense and patchy (Törnqvist et al, 2000). However, GDNF treatment of mature dopamine grafts did not affect survival and outgrowth from grafted dopamine neurons (Johansson et al, 1995;Winkler et al, 2006), but enhanced nerve fiber formation within the grafts, a phenomenon also found using other factors . This phenomenon may cause reduced graft function since high dopamine activity surrounding the grafted dopamine neurons should, theoretically, shut down neuronal activity for the dopamine neurons that target the host striatum, thus reducing dopamine release in the host target.…”
Section: Introductionmentioning
confidence: 74%
“…Since a large window for improvement exists with regard to graft viability and neurite outgrowth, transplants may be able to provide even greater benefit to patients with PD following further refinement of this procedure. Toward this end, trophic factors and trophic factor-secreting cells have been shown to augment the viability and functional benefits of fetal nigral grafts (Sauer et al, 1993;Johansson et al, 1995;Takayama et al, 1995;Yurek et al, 1996). It has recently been demonstrated that treatment of fetal rodent nigral cells with antioxidents (Nakao et al, 1995) or lazeroids (Nakao et al, 1994) augments their viability following grafting as well.…”
Section: Dmentioning
confidence: 95%
“…However, it is a large protein and has to be delivered directly to the brain rather than given peripherally. When this is done, GDNF can support the survival and outgrowth of DA neurons following transplantation (Johansson et al, 1995). In addition, GDNF added to cell suspensions of embryonic ventral mesencephalic (VM) tissue improves the survival of DA neurons following grafting into the denervated striatum (Apostolides et al, 1998;Mehta et al, 1998;Sullivan et al, 1998).…”
mentioning
confidence: 99%